Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Feb;55(2):444–450.

Murine anti-lymphocyte monoclonal antibodies fail to act as opsonins for allogeneic human peripheral blood polymorphonuclear phagocytes.

D M Roberton, G M Georgiou, W M Ellis, C S Hosking
PMCID: PMC1535802  PMID: 6199142

Abstract

Seven murine monoclonal antibodies (MoAbs) to antigenic determinants present on human lymphocytes did not promote phagocytosis of allogeneic human lymphocytes by human peripheral blood polymorphonuclear leucocytes (PML). Similarly there was no significant metabolic activation of PML as determined by incorporation of radiolabelled iodide. The opsonic activity of MoAbs was not enhanced by addition of human or rabbit complement nor by the use of sheep anti-mouse IgG, rabbit anti-mouse immunoglobulin or goat anti-mouse immunoglobulin as second antibody. Whole serum from mice immunized with human lymphocytes did not act as an opsonin when tested with human PML. Hyperimmune mouse antiserum to Bordetella pertussis antigen acted only weakly as an opsonin. Human PML may not have an in vivo role in the removal of allogeneic lymphocytes treated with murine anti-lymphocyte MoAbs.

Full text

PDF
444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borst J., Prendiville M. A., Terhorst C. Complexity of the human T lymphocyte-specific cell surface antigen T3. J Immunol. 1982 Apr;128(4):1560–1565. [PubMed] [Google Scholar]
  2. Cosimi A. B., Burton R. C., Colvin R. B., Goldstein G., Delmonico F. L., LaQuaglia M. P., Tolkoff-Rubin N., Rubin R. H., Herrin J. T., Russell P. S. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation. 1981 Dec;32(6):535–539. doi: 10.1097/00007890-198112000-00018. [DOI] [PubMed] [Google Scholar]
  3. Filipovich A. H., McGlave P. B., Ramsay N. K., Goldstein G., Warkentin P. I., Kesey J. H. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet. 1982 Jun 5;1(8284):1266–1269. doi: 10.1016/s0140-6736(82)92840-9. [DOI] [PubMed] [Google Scholar]
  4. Goldstein I. M., Kaplan H. B., Radin A., Frosch M. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol. 1976 Oct;117(4):1282–1287. [PubMed] [Google Scholar]
  5. Good R. A. Toward safer marrow transplantation. N Engl J Med. 1982 Feb 18;306(7):421–423. doi: 10.1056/NEJM198202183060710. [DOI] [PubMed] [Google Scholar]
  6. Griffin F. M., Jr, Griffin J. A., Silverstein S. C. Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. J Exp Med. 1976 Sep 1;144(3):788–809. doi: 10.1084/jem.144.3.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kamoun M., Martin P. J., Hansen J. A., Brown M. A., Siadak A. W., Nowinski R. C. Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med. 1981 Jan 1;153(1):207–212. doi: 10.1084/jem.153.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klebanoff S. J., Clark R. A. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med. 1977 Mar;89(3):675–686. [PubMed] [Google Scholar]
  9. Messner R. P., Jelinek J. Receptors for human gamma G globulin on human neutrophils. J Clin Invest. 1970 Dec;49(12):2165–2171. doi: 10.1172/JCI106435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Prentice H. G., Blacklock H. A., Janossy G., Bradstock K. F., Skeggs D., Goldstein G., Hoffbrand A. V. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet. 1982 Mar 27;1(8274):700–703. doi: 10.1016/s0140-6736(82)92619-8. [DOI] [PubMed] [Google Scholar]
  11. Prentice H. G. OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation. J Clin Immunol. 1982 Jul;2(3 Suppl):148S–153S. [PubMed] [Google Scholar]
  12. Ramsay N. K., Kersey J. H., Robison L. L., McGlave P. B., Woods W. G., Krivit W., Kim T. H., Goldman A. I., Nesbit M. E., Jr A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med. 1982 Feb 18;306(7):392–397. doi: 10.1056/NEJM198202183060703. [DOI] [PubMed] [Google Scholar]
  13. Reinherz E. L., Geha R., Rappeport J. M., Wilson M., Penta A. C., Hussey R. E., Fitzgerald K. A., Daley J. F., Levine H., Rosen F. S. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1982 Oct;79(19):6047–6051. doi: 10.1073/pnas.79.19.6047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Roberton D. M., Dhanjal N. K., Levinsky R. J., Mowbray J. F., Turner M. W. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization. Clin Exp Immunol. 1981 Jan;43(1):208–214. [PMC free article] [PubMed] [Google Scholar]
  15. Rodt H., Kolb H. J., Netzel B., Haas R. J., Wilms K., Götze C. B., Link H., Thierfelder S. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc. 1981 Mar;13(1 Pt 1):257–261. [PubMed] [Google Scholar]
  16. Sharp T. G., Sachs D. H., Fauci A. S., Messerschmidt G. L., Rosenberg S. A. T cell depletion of human bone marrow using monoclonal antibody and complement-mediated lysis. Transplantation. 1983 Feb;35(2):112–120. doi: 10.1097/00007890-198302000-00002. [DOI] [PubMed] [Google Scholar]
  17. Shield C. F., 3rd, Cosimi A. B., Tolkoff-Rubin N., Rubin R. H., Herrin J., Russell P. S. Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation. 1979 Dec;28(6):461–464. [PubMed] [Google Scholar]
  18. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  19. van Furth R., Raeburn J. A., van Zwet T. L. Characteristics of human mononuclear phagocytes. Blood. 1979 Aug;54(2):485–500. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES